Literature DB >> 25775507

The nucleolar ubiquitin-specific protease USP36 deubiquitinates and stabilizes c-Myc.

Xiao-Xin Sun1, Xia He2, Li Yin3, Masayuki Komada4, Rosalie C Sears5, Mu-Shui Dai5.   

Abstract

c-Myc protein stability and activity are tightly regulated by the ubiquitin-proteasome system. Aberrant stabilization of c-Myc contributes to many human cancers. c-Myc is ubiquitinated by SCF(Fbw7) (a SKP1-cullin-1-F-box complex that contains the F-box and WD repeat domain-containing 7, Fbw7, as the F-box protein) and several other ubiquitin ligases, whereas it is deubiquitinated and stabilized by ubiquitin-specific protease (USP) 28. The bulk of c-Myc degradation appears to occur in the nucleolus. However, whether c-Myc is regulated by deubiquitination in the nucleolus is not known. Here, we report that the nucleolar deubiquitinating enzyme USP36 is a novel c-Myc deubiquitinase. USP36 interacts with and deubiquitinates c-Myc in cells and in vitro, leading to the stabilization of c-Myc. This USP36 regulation of c-Myc occurs in the nucleolus. Interestingly, USP36 interacts with the nucleolar Fbw7γ but not the nucleoplasmic Fbw7α. However, it abolished c-Myc degradation mediated both by Fbw7γ and by Fbw7α. Consistently, knockdown of USP36 reduces the levels of c-Myc and suppresses cell proliferation. We further show that USP36 itself is a c-Myc target gene, suggesting that USP36 and c-Myc form a positive feedback regulatory loop. High expression levels of USP36 are found in a subset of human breast and lung cancers. Altogether, these results identified USP36 as a crucial and bono fide deubiquitinating enzyme controlling c-Myc's nucleolar degradation pathway.

Entities:  

Keywords:  USP36; c-Myc; deubiquitination; nucleolus; ubiquitination

Mesh:

Substances:

Year:  2015        PMID: 25775507      PMCID: PMC4378440          DOI: 10.1073/pnas.1411713112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Ubiquitylation of the amino terminus of Myc by SCF(β-TrCP) antagonizes SCF(Fbw7)-mediated turnover.

Authors:  Nikita Popov; Christina Schülein; Laura A Jaenicke; Martin Eilers
Journal:  Nat Cell Biol       Date:  2010-09-19       Impact factor: 28.824

Review 2.  MYC as a regulator of ribosome biogenesis and protein synthesis.

Authors:  Jan van Riggelen; Alper Yetil; Dean W Felsher
Journal:  Nat Rev Cancer       Date:  2010-04       Impact factor: 60.716

Review 3.  Reflecting on 25 years with MYC.

Authors:  Natalie Meyer; Linda Z Penn
Journal:  Nat Rev Cancer       Date:  2008-12       Impact factor: 60.716

4.  Positive regulation of p53 stability and activity by the deubiquitinating enzyme Otubain 1.

Authors:  Xiao-Xin Sun; Kishore B Challagundla; Mu-Shui Dai
Journal:  EMBO J       Date:  2011-11-29       Impact factor: 11.598

5.  A conserved deubiquitinating enzyme controls cell growth by regulating RNA polymerase I stability.

Authors:  Lauren A Richardson; Benjamin J Reed; J Michael Charette; Emily F Freed; Eric K Fredrickson; Melissa N Locke; Susan J Baserga; Richard G Gardner
Journal:  Cell Rep       Date:  2012-08-16       Impact factor: 9.423

6.  Fbw7α and Fbw7γ collaborate to shuttle cyclin E1 into the nucleolus for multiubiquitylation.

Authors:  Nimesh Bhaskaran; Frank van Drogen; Hwee-Fang Ng; Raman Kumar; Susanna Ekholm-Reed; Matthias Peter; Olle Sangfelt; Steven I Reed
Journal:  Mol Cell Biol       Date:  2012-10-29       Impact factor: 4.272

Review 7.  MYC degradation.

Authors:  Amy S Farrell; Rosalie C Sears
Journal:  Cold Spring Harb Perspect Med       Date:  2014-03-01       Impact factor: 6.915

8.  Nucleophosmin/B23 regulates ubiquitin dynamics in nucleoli by recruiting deubiquitylating enzyme USP36.

Authors:  Akinori Endo; Naomi Kitamura; Masayuki Komada
Journal:  J Biol Chem       Date:  2009-08-13       Impact factor: 5.157

Review 9.  Crosstalk between c-Myc and ribosome in ribosomal biogenesis and cancer.

Authors:  Mu-Shui Dai; Hua Lu
Journal:  J Cell Biochem       Date:  2008-10-15       Impact factor: 4.429

10.  CDK-mediated activation of the SCF(FBXO) (28) ubiquitin ligase promotes MYC-driven transcription and tumourigenesis and predicts poor survival in breast cancer.

Authors:  Diana Cepeda; Hwee-Fang Ng; Hamid Reza Sharifi; Salah Mahmoudi; Vanessa Soto Cerrato; Erik Fredlund; Kristina Magnusson; Helén Nilsson; Alena Malyukova; Juha Rantala; Daniel Klevebring; Francesc Viñals; Nimesh Bhaskaran; Siti Mariam Zakaria; Aldwin Suryo Rahmanto; Stefan Grotegut; Michael Lund Nielsen; Cristina Al-Khalili Szigyarto; Dahui Sun; Mikael Lerner; Sanjay Navani; Martin Widschwendter; Mathias Uhlén; Karin Jirström; Fredrik Pontén; James Wohlschlegel; Dan Grandér; Charles Spruck; Lars-Gunnar Larsson; Olle Sangfelt
Journal:  EMBO Mol Med       Date:  2013-06-14       Impact factor: 12.137

View more
  74 in total

1.  Deubiquitinating c-Myc: USP36 steps up in the nucleolus.

Authors:  Xiao-Xin Sun; Rosalie C Sears; Mu-Shui Dai
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 2.  Targeting the turnover of oncoproteins as a new avenue for therapeutics development in castration-resistant prostate cancer.

Authors:  Shan Wang; Dede N Ekoue; Ganesh V Raj; Ralf Kittler
Journal:  Cancer Lett       Date:  2018-09-11       Impact factor: 8.679

3.  SUMO protease SENP1 deSUMOylates and stabilizes c-Myc.

Authors:  Xiao-Xin Sun; Yingxiao Chen; Yulong Su; Xiaoyan Wang; Krishna Mohan Chauhan; Juan Liang; Colin J Daniel; Rosalie C Sears; Mu-Shui Dai
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-10       Impact factor: 11.205

4.  Loss of the deubiquitinase USP36 destabilizes the RNA helicase DHX33 and causes preimplantation lethality in mice.

Authors:  Julia M Fraile; Diana Campos-Iglesias; Francisco Rodríguez; Aurora Astudillo; Roser Vilarrasa-Blasi; Nuria Verdaguer-Dot; Miguel A Prado; Joao A Paulo; Steven P Gygi; José I Martín-Subero; José M P Freije; Carlos López-Otín
Journal:  J Biol Chem       Date:  2017-12-22       Impact factor: 5.157

Review 5.  The role of ubiquitination in tumorigenesis and targeted drug discovery.

Authors:  Lu Deng; Tong Meng; Lei Chen; Wenyi Wei; Ping Wang
Journal:  Signal Transduct Target Ther       Date:  2020-02-29

Review 6.  Cellular functions of stem cell factors mediated by the ubiquitin-proteasome system.

Authors:  Jihye Choi; Kwang-Hyun Baek
Journal:  Cell Mol Life Sci       Date:  2018-02-08       Impact factor: 9.261

7.  A detrimental mutation on USP40 unlocks the tumorigenesis in a rare case of lung cancer.

Authors:  Zhi-Hong Xu; Hui Wang; Xiao-Yang Ji; Fei-Xu Zhang; Bei-Li Gao; Jia-An Hu; Jing Zheng
Journal:  Int J Clin Exp Pathol       Date:  2019-03-01

8.  Ubiquitin-specific Protease 36 (USP36) Controls Neuronal Precursor Cell-expressed Developmentally Down-regulated 4-2 (Nedd4-2) Actions over the Neurotrophin Receptor TrkA and Potassium Voltage-gated Channels 7.2/3 (Kv7.2/3).

Authors:  Begoña Anta; Carlos Martín-Rodríguez; Carolina Gomis-Perez; Laura Calvo; Saray López-Benito; Andrés A Calderón-García; Cristina Vicente-García; Álvaro Villarroel; Juan C Arévalo
Journal:  J Biol Chem       Date:  2016-07-21       Impact factor: 5.157

9.  PELI1 expression is correlated with MYC and BCL6 expression and associated with poor prognosis in diffuse large B-cell lymphoma.

Authors:  Ji-Young Choe; Mira Park; Ji Yun Yun; Hee Young Na; Heounjeong Go; Hyun-Jung Kim; Sohee Oh; Ji Eun Kim
Journal:  Mod Pathol       Date:  2016-07-29       Impact factor: 7.842

10.  YY1-mediated reticulocalbin-2 upregulation promotes the hepatocellular carcinoma progression via activating MYC signaling.

Authors:  Chengjie Mei; Xiang Jiang; Yang Gu; Xiaoling Wu; Weijie Ma; Xi Chen; Ganggang Wang; Ye Yao; Yingyi Liu; Zhonglin Zhang; Yufeng Yuan
Journal:  Am J Cancer Res       Date:  2021-05-15       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.